Skip to main content
Premium Trial:

Request an Annual Quote

LJL Biosystems’ Private Placement Brings $19 M

Premium

S

UNNYVALE, Calif.--LJL BioSystems has entered into purchase agreements for a private placement of 1.76 million shares of common stock at $11 each to new and current investors for approximately $19 million. The company intends to use net proceeds from the private placement for working capital and other general corporate purposes.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.